Matthew Doctor - Regis Common CEO
| RGS Stock | USD 21.31 1.19 5.29% |
CEO
Matthew Doctor is Interim Chief Executive Officer, Chief Strategy Officer, Executive Vice President of Regis Common since 2021.
| Age | 37 |
| Tenure | 3 years |
| Address | 3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416 |
| Phone | 952-947-7777 |
| Web | https://www.regiscorp.com |
Matthew Doctor Latest Insider Activity
Tracking and analyzing the buying and selling activities of Matthew Doctor against Regis Common stock is an integral part of due diligence when investing in Regis Common. Matthew Doctor insider activity provides valuable insight into whether Regis Common is net buyers or sellers over its current business cycle. Note, Regis Common insiders must abide by specific rules, including filing SEC forms every time they buy or sell Regis Common'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Matthew Doctor over three months ago Disposition of 211 shares by Matthew Doctor of Regis Common at 12.35 subject to Rule 16b-3 |
Regis Common Management Efficiency
The company has Return on Asset of 0.0192 % which means that on every $100 spent on assets, it made $0.0192 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.8145 %, implying that it generated $0.8145 on every 100 dollars invested. Regis Common's management efficiency ratios could be used to measure how well Regis Common manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.27 in 2024. Return On Capital Employed is likely to gain to 0.05 in 2024. At this time, Regis Common's Non Current Assets Total are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 30 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 20.2 M in 2024.Similar Executives
| Found 4 records | CEO Age | ||
| Stephen Kramer | Bright Horizons Family | 53 | |
| Scott Milford | XWELL Inc | 60 | |
| Jeffrey Jones | HR Block | 52 | |
| Jeffrey II | HR Block | 56 | |
Management Performance
| Return On Equity | 0.81 | ||||
| Return On Asset | 0.0192 |
Regis Common Leadership Team
Elected by the shareholders, the Regis Common's board of directors comprises two types of representatives: Regis Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Regis. The board's role is to monitor Regis Common's management team and ensure that shareholders' interests are well served. Regis Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Regis Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jim Lain, Chief Operating Officer, Executive Vice President | ||
| James Townsend, Executive Vice President Chief Marketing Officer | ||
| Jackie Lang, Senior UK | ||
| Mark Light, Independent Director | ||
| Michael Merriman, Independent Director | ||
| Daniel Beltzman, Independent Chairman of the Board | ||
| Virginia Gambale, Lead Independent Director | ||
| Chad Kapadia, Executive Vice President, Chief Technology Officer, and Head of Product Engineering | ||
| Kersten Zupfer, Chief Financial Officer, Executive Vice President | ||
| Hugh Sawyer, President, Chief Executive Officer, Director | ||
| Laura Alexander, Senior Vice President, Chief Merchandising Officer | ||
| James Suarez, Executive Education | ||
| Mark Fosland, Senior Relations | ||
| David Grissen, Chairman of the Board | ||
| Shawn Moren, Chief Human Resource Officer, Senior Vice President | ||
| Amanda Rusin, Senior Vice President, General Counsel, Secretary, Chief Development Officer | ||
| Shawn Thompson, President of Supercuts | ||
| Lockie Andrews, Independent Director | ||
| Matthew Doctor, Interim Chief Executive Officer, Chief Strategy Officer, Executive Vice President | ||
| Andra Terrell, Gen VP | ||
| David Williams, Independent Chairman of the Board | ||
| David Kunin, Vice Foundation | ||
| Jennifer JD, Assistant Secretary | ||
| M Rhoades, Independent Director | ||
| Michael Ferranti, Executive Officer | ||
| John Davi, Executive Vice President, Chief Technology Officer | ||
| Michelle DeVore, Senior Marketing | ||
| Eric Bakken, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary, President of Franchise | ||
| Felipe Athayde, President, Chief Executive Officer, Director | ||
| Michael Mansbach, Independent Director | ||
| Elizabeth Murphy, VP Controller |
Regis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Regis Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.81 | ||||
| Return On Asset | 0.0192 | ||||
| Profit Margin | 0.45 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 423.05 M | ||||
| Shares Outstanding | 2.28 M | ||||
| Shares Owned By Insiders | 12.77 % | ||||
| Shares Owned By Institutions | 20.45 % | ||||
| Number Of Shares Shorted | 48.25 K | ||||
| Price To Earning | 186.46 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Regis Stock Analysis
When running Regis Common's price analysis, check to measure Regis Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regis Common is operating at the current time. Most of Regis Common's value examination focuses on studying past and present price action to predict the probability of Regis Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regis Common's price. Additionally, you may evaluate how the addition of Regis Common to your portfolios can decrease your overall portfolio volatility.